Literature DB >> 33600920

Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19.

C Trojaniello1, M G Vitale1, P A Ascierto2.   

Abstract

Entities:  

Year:  2021        PMID： 33600920      PMCID： PMC7884251          DOI： 10.1016/j.annonc.2021.02.008

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  7 in total

1.  COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma.

Authors:  M Arenbergerova; S Gkalpakiotis; P Arenberger; A Fialova; M Pasek
Journal:  J Dermatolog Treat       Date:  2020-10-22       Impact factor: 3.359

2.  COVID-19 and immune checkpoint inhibitors: initial considerations.

Authors:  Ryan J Sullivan; Douglas B Johnson; Brian I Rini; Tomas G Neilan; Christine M Lovly; Javid J Moslehi; Kerry L Reynolds
Journal:  J Immunother Cancer       Date:  2020-05       Impact factor: 13.751

3.  Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit.

Authors:  P Quaglino; P Fava; M Brizio; E Marra; M Rubatto; A Agostini; L Tonella; S Ribero; M T Fierro
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-04       Impact factor: 6.166

4.  COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study.

Authors:  Jessica J Manson; Colin Crooks; Meena Naja; Amanda Ledlie; Bethan Goulden; Trevor Liddle; Emon Khan; Puja Mehta; Lucia Martin-Gutierrez; Kirsty E Waddington; George A Robinson; Liliana Ribeiro Santos; Eve McLoughlin; Antonia Snell; Christopher Adeney; Ina Schim van der Loeff; Kenneth F Baker; Christopher J A Duncan; Aidan T Hanrath; B Clare Lendrem; Anthony De Soyza; Junjie Peng; Hajar J'Bari; Mandy Greenwood; Ellie Hawkins; Hannah Peckham; Michael Marks; Tommy Rampling; Akish Luintel; Bryan Williams; Michael Brown; Mervyn Singer; Joe West; Elizabeth C Jury; Matthew Collin; Rachel S Tattersall
Journal:  Lancet Rheumatol       Date:  2020-08-21

5.  COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.

Authors:  Marina Chiara Garassino; Jennifer G Whisenant; Li-Ching Huang; Annalisa Trama; Valter Torri; Francesco Agustoni; Javier Baena; Giuseppe Banna; Rossana Berardi; Anna Cecilia Bettini; Emilio Bria; Matteo Brighenti; Jacques Cadranel; Alessandro De Toma; Claudio Chini; Alessio Cortellini; Enriqueta Felip; Giovanna Finocchiaro; Pilar Garrido; Carlo Genova; Raffaele Giusti; Vanesa Gregorc; Francesco Grossi; Federica Grosso; Salvatore Intagliata; Nicla La Verde; Stephen V Liu; Julien Mazieres; Edoardo Mercadante; Olivier Michielin; Gabriele Minuti; Denis Moro-Sibilot; Giulia Pasello; Antonio Passaro; Vieri Scotti; Piergiorgio Solli; Elisa Stroppa; Marcello Tiseo; Giuseppe Viscardi; Luca Voltolini; Yi-Long Wu; Silvia Zai; Vera Pancaldi; Anne-Marie Dingemans; Jan Van Meerbeeck; Fabrice Barlesi; Heather Wakelee; Solange Peters; Leora Horn
Journal:  Lancet Oncol       Date:  2020-06-12       Impact factor: 41.316

6.  Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.

Authors:  G Curigliano; S Banerjee; A Cervantes; M C Garassino; P Garrido; N Girard; J Haanen; K Jordan; F Lordick; J P Machiels; O Michielin; S Peters; J Tabernero; J Y Douillard; G Pentheroudakis
Journal:  Ann Oncol       Date:  2020-07-31       Impact factor: 32.976

7.  Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers.

Authors:  Jia Luo; Hira Rizvi; Jacklynn V Egger; Isabel R Preeshagul; Jedd D Wolchok; Matthew D Hellmann
Journal:  Cancer Discov       Date:  2020-05-12       Impact factor: 38.272
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.